Fundz

Bond Biosciences reported raising $2.63 Million in an initial SEC Form D filing, from an offering of $4.5 Million

PRIVATESep 06, 2024$2.6M of $4.5M raised

Amount Raised

$2.63 Million

$2.63 Million sold, per SEC Form D (first sale Aug 22, 2024)

Round Type

Seed

ParkvilleBiotechnologyHealthcareHealth CareScience And Engineering

Who to call at Bond Biosciences, and when

A new round usually means Bond Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bond Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bond Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bond Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bond Biosciences

Location

170 English Landing Drive

Parkville, Missouri, United States

About

Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bond Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDanny G., Director of Business Development hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Bond Biosciences's next move

See what Strategic adds

Bond Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.